IVVD Invivyd, Inc.
$0.59▼ -0.08%
Healthcare
Other
After hours
$0.60▲ +1.92%
Oct 27, 5:58 PM ET
Volume 4.25M
Avg Volume (10D) 3.71M
Key Metrics & Fundamentals
Market Cap
$173.52M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.53 - 3.07
% vs 50 MA
-26.96%
% vs 200 MA
-50.64%
RSI-14
35.7
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.96
Free Cash Flow
-$43.52M
Gross Rev
$14.29M
Gross Profit
$13.01M
EBITDA
-$45.18M
COGS
$1.27M
Operating Exp
$58.83M
Operating Income
-$45.82M
EBIT
-$45.82M
Pretax Income
-$44.39M
Net Income
-$44.39M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
GlobeNewswire · Oct 21, 2026 7:01 AM ET
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
GlobeNewswire · Oct 14, 2026 7:01 AM ET
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 5, 2026 7:01 AM ET
Invivyd’s VYD2311 Phase III Study Meets Safety Goals, Eyes FDA Accelerated Approval
MarketBeat · Oct 4, 2026 10:02 PM ET
Invivyd’s Covid-directed mAb hits Phase III safety goals
Clinical Trials Arena · Sep 30, 2026 12:19 PM ET
Invivyd Reports Positive Phase 3 LIBERTY Results for VYD2311 and Plans Accelerated Approval Submission
InvestorsHub · Sep 29, 2026 10:40 AM ET
Invivyd's VYD2311 Meets Primary Goals in Head-to-Head mRNA Vaccine Trial
MT Newswires · Sep 29, 2026 8:46 AM ET
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
GlobeNewswire · Sep 29, 2026 7:01 AM ET
3 Small-Cap Biotechs With Binary Catalysts on the Calendar
MarketBeat · Sep 13, 2026 10:50 AM ET
Invivyd to Participate in Upcoming September Investor Conferences
GlobeNewswire · Sep 8, 2026 7:01 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IVVD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.